🔎 Trials Near Me

Hjem › Type 2-diabetes › North Carolina

Type 2-diabetes kliniske forsøg i North Carolina

36 studier for Type 2-diabetes søger deltagere på steder i North Carolina.

Byer i North Carolina

Officiel studietekst (engelsk)

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

  • Duke University, Durham
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06906640

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)

  • Duke University, Durham
  • Houston Methodist, Houston
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06906627

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • PharmQuest Life Sciences LLC, Greensboro
  • Accellacare Wilmington, Wilmington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cary Cardiology, Cary
  • The University of North Carolina at Chapel Hill, Chapel Hill
  • Physicians East, PA, Greenville
  • og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  • Javara Inc. - Cape Fear Valley Medical Center, Fayetteville
  • PharmQuest Life Sciences, Greensboro
  • Centricity Research - Morehead City, Morehead City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07754461

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University Hospital, Durham
  • Durham Veterans Affairs Medical Center (Durham VAMC), Durham
  • og 2 flere
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Medication Management, LLC, Greensboro
  • Accellacare - Wilmington, Wilmington
  • Jeffrey Coleman, OD, Wilmington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • PharmQuest Life Sciences, LLC, Greensboro
  • West Clinical Research, Morehead City
  • Trial Management Associates - Wilmington - Floral Parkway, Wilmington
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Monroe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Charlotte
  • AURORA-2 Clinical Site, Durham
  • AURORA-2 Clinical Site, Greenville
  • og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

  • M3 Wake Research, Inc - M3 WR, Raleigh
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centricity Research Morehead City Multispeciality, Morehead City
  • Wake Forest University Health Sciences, Winston-Salem
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Lucas Research, Inc., Morehead City
  • Shelby Clinical Research, Shelby
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  • PharmQuest, Greensboro
  • Piedmont Healthcare Statesville, Statesville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Eastern Nephrology Associates - Greenville West, Greenville
  • Eastern Nephrology Associates - New Bern, New Bern
  • Brookview Hills Research Associates, LLC, Winston-Salem
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 11. sep. 2026 · NCT07271186

A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

  • PharmQuest, Greensboro
  • KDCILM, LLC & Accellacare US, Inc., Wilmington
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07668388

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Durham
  • Research Site, Morehead City
  • Research Site, Raleigh
  • og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Physicians East, Greenville
  • Lucas Research Inc, Morehead City
  • og 1 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • West Clinical Research, Morehead City
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

  • Research Site, Kinston
  • Research Site, Raleigh
  • Research Site, Winston-Salem
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • Carteret Medical Group, Morehead City
  • Piedmont Healthcare/Research, Statesville
  • Accellacare, Winston-Salem
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Raleigh
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

  • Centricity Research - Morehead City, Morehead City
Rekrutterer
Alder 18 til 80 · Alle køn · Opdateret 28. aug. 2026 · NCT07599982

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

  • Lucas Research, Inc., Morehead City
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT07527650

Integrating New Skills Into Diabetes Education With CGM

  • University of North Carolina at Chapel Hill, Chapel Hill
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 14. aug. 2026 · NCT07463209

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • UNC Children's Hospital, Chapel Hill
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

  • Research Site, Cary
  • Research Site, Morehead City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT07664553

Human Immunodeficiency Virus (HIV) Food Insecurities

  • Wake Forest Health Sciences, Winston-Salem
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT04943861

Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  • Mountain Area Health Education Center, Asheville
  • Accellacare, Wilmington
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07521475

CGM for Management of Type 2 Diabetes in Pregnancy

  • University of North Carolina - Chapel Hill, Chapel Hill
Rekrutterer
Alder 18 til 50 · Kvinder · Opdateret 29. jun. 2026 · NCT06628453

Culturally Tailored Program for Food-Insecure Adults: SPICE-D

  • Wake Forest University Health Sciences, Winston-Salem
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 26. maj 2026 · NCT07361341

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

  • Atrium Health, Charlotte
  • Wake Forest University, Winston-Salem
RekruttererObservationsstudie
Alder 8 til 15 · Alle køn · Opdateret 7. maj 2026 · NCT06525259

The Treatment of Painful Diabetic Neuropathy With Diet

  • AdventHealth Hendersonville, Hendersonville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT07509671

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

  • Duke University - Charlotte Study Sites, Charlotte
  • Duke University - Duke Study Site, Durham
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2025 · NCT05129345

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

  • Foot and Ankle Specialists of the Mid-Atlantic, Raleigh
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 10. feb. 2025 · NCT06681428

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.